Insulin-Dependence Predicts Disease-Specific Survival in Pancreatic Neuroendocrine Tumor Patients

HPB - United Kingdom
doi 10.1016/j.hpb.2019.03.093
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Nomogram Individually Predicts the Overall Survival of Patients With Gastroenteropancreatic Neuroendocrine Neoplasms

British Journal of Cancer
Cancer ResearchOncology
2017English

Increased HSF1 Expression Predicts Shorter Disease-Specific Survival of Prostate Cancer Patients Following Radical Prostatectomy

Oncotarget
Oncology
2018English

Mean Platelet Volume Predicts Survival in Pancreatic Cancer Patients With Synchronous Liver Metastases

Scientific Reports
Multidisciplinary
2018English

Disparities in Survival Among Patients With Pancreatic Neuroendocrine Tumor Using the National Cancer Database: Effects of Insurance Status and Treatment Facility

HPB
HepatologyGastroenterology
2019English

Gastric Gastrointestinal Stromal Tumor and Neuroendocrine Pancreatic Tumor: Always Neurofibromatosis?

Endoscopic Ultrasound
HepatologyNuclear MedicineRadiologyImagingGastroenterology
2014English

Plasma Insulin in Pancreatic Disease

Gut
Gastroenterology
1970English

Metabolic Tumor Volume Predicts Disease Progression and Survival in Patients With Squamous Cell Carcinoma of the Anal Canal

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

Two Well-Differentiated Pancreatic Neuroendocrine Tumor Mouse Models

Cell Death and Differentiation
Cell BiologyMolecular Biology
2019English

Therapeutic Targeting of Tumor-Associated Macrophages in Pancreatic Neuroendocrine Tumors

International Journal of Cancer
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy